drugset / Trial / NCT02632110

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

NCT02632110 ↗

Phase 2 Completed 137 enrolled DUSA Pharmaceuticals, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the viability of microneedle lesion preparation (MN) to enhance treatment benefit when performed prior to ALA PDT to an actinic keratosis (AK) field on the face.

Timeline

Start
2016-03
Primary completion
2016-09-12
Completion
2016-09-12

Drugs

EvaluationDrugModalityDoseRoute
Subject ALA Unknown 20 % Topical

Indications